NUVB Nuvation Bio Inc - Ordinary Shares - Class A

$NUVB two weeks (maybe) until earnings and a proper update. Looking forward to it and to watch this thing climb back to $9 and beyond in 2027.

$NUVB if you don’t think this is intentionally being brought down you need to give your head a shake. Look at the fundamentals. Nothing but good news and reiterated buys and initiated buys from analysts. Nothing has changed for the worse. This is 1000% market manipulation. Funds wanted in lower so they brought it down lower. They wouldn’t do it for you or I but that’s the game I guess.

$NUVB per LinkedIn page, NUVB released new data at ESMO this past weekend. I guess we will get info in earnings release.

$NUVB Fellow longs: For almost two years here I have been an openly admitted & biased bull but transparent with my opinions. So often you saw me posting my shares purchases just so you know that I am not bullshit you. And honestly I don’t like to average up but sincerely hope they could dump their shares at $3 or $2 for whatever reason so I don’t have to wait. Been buying lately and Below are catch of the day. You should only do it on your own terms because again only you know best of your financial conditions. Survival first. BLTA

$NUVB with an all time high of short interest, can you imaging the volcano if NUVB came out with surprising spectacular news?

$NUVB Guys, don't worry. Nothing has changed here. Doesn't it seem strange to you that it dropped like this for no apparent reason? As our colleague mentioned, perhaps the person who was always manipulating this stock has cashed out. Personally, I believe it’s going to skyrocket—it’s just a matter of when.

$NUVB Hung is expanding to Europe, in order to get later the European approval easier without doing an extra phase which will take time! He knows that the drug works, so he is trying not to loose time! Company has plenty of cash, so he is not worried! Probably he knows Ibtrozi is going very good in sales, maybe a good sign for next week!

$NUVB absolutely my favorite stock I own.....saving more and more lives everyday, giving hope to so many. will never stop adding this one

$NUVB These huge green closing candles show exactly how manipulated the SP is. Add as many on those dips as you can. This will literally jump a few legs up in Q4.

$NUVB An interesting day worth remembering and revisiting later. Close to 15 million shares changed hands without any good or bad news, not in Triple Witching day of 9/18 but some funds picked the 1st Oct Friday to execute this huge volumes targeting a small biotech led by a industry well known founder CEO who sold his last company Medivation for $14 Billions to PFZ 10 yrs ago. Btw Dr Hung owns 60 million shares/RSU so he has $25 M paper losses today & $150+M losses in past 40-day when NUVB reached $7.58 high on 8/19/26. So 100% it caught his attention. The Question is what’s he going to do about it? IMO, the June Offering was a good idea but priced too low so the over hang provided the hedge funds a free bank run for too long. Longs can find my posts using ADPT as the sample to point out that NUVB should’ve been out of the hedge overhang in almost 3-M long. For that I blame all on the CFO Phillips executed poorly and stopped our momentum and hurt us all. Better days ahead.

$NUVB Commercial ramp and international expansion of Ibtrozi, Sigma trial, and DDC platform. Don’t let bears FUD you out of this one

$NUVB Possibility of a European partnership with Safusidenib? Similar to their Eisai deal?

$NUVB NUVB doesn't necessarily need 2,000–3,000 new patients annually to create a billion-dollar drug. If treatment lasts sufficiently long, (40m) 1,200 new patients per year could be enough. 100 new first-line patients every month, and each patient stays on treatment for an average of 40 months( i am not using 50m which they got recently..) , annual U.S. net revenue could approach $1 billion from those first-line patients alone. Using our assumed $245,000 net annual revenue per patient: MATURE ANNUAL REVENUE SCENARIO $980 million/year 100 new patients/month × 40 months of treatment × $245,000 per patient-year. So as i said, give it some time to roll, we are still in the beginning of a beautiful journey.. Right now we are at 50 patients per month.. Patients will stay in Ibtrozi, because it is best in class , with fewer side effects than the others.. We are sitting in a gold mine here, but MM and funds trying their best to hide it from us..

$NUVB Yesterday big funds, scooped more than a 1.5m shares.. they waited the right time to press the button and they will continue to do that in those levels, they have plenty of patience and money! Regarding the drugs, especially Ibtrozi, we know that 3000 patients is the pool every year, which means 250 patients every month... NUVB already is having 50 patients so far from 1st line, which means 1/5 already is taken from the company which is a great deal.. If you read the latest transcript, Hung said that they will soon take all the patients from the current competitor drugs.. but the biggest opponent is the IO chemo.. His words " If we were to double from IO chemo, that would take us to 100, and if we were to double that from testing, that could take us to 200".. So give it more time for the doctors to educate themselves, it takes time to change the way someone's works.. New guidelines, more conferences, better testing will bring us to the top! Less than 2 years, i can see that happen

$NUVB the price tape remains bearish because three consecutive down sessions after Friday's heavy-volume break are significant. But today's underlying smart-money indicators are considerably less bearish: volume normalized substantially, dark-pool participation was ordinary, and options flow actually leaned toward calls.

$NUVB just curious. If the price was at $7.30 and I wanted to buy cheaper shares. Would the market makers drop it for me lol

$NUVB how to make money in the market: Step 1 - buy low Step 2 - sell high. We are at Step 1 here. This isn’t something to complain about; it is an opportunity to be excited about.

$NUVB Someone doubled down Essex Investment Management Co Llc reports 100.42% increase in ownership of NUVB / Nuvation Bio Inc. On October 19, 2026 - Essex Investment Management Co Llc filed a 13F-HR form disclosing ownership of 1,344,871 shares of Nuvation Bio Inc. (US:NUVB) valued at $7,531,278 USD as of September 30, 2026. The entity filed a previous 13F-HR on August 6, 2026 disclosing 671,041 shares of Nuvation Bio Inc.. This represents a change in shares of 100.42% during the quarter. The current value of the position is $6,522,624 USD.

$NUVB I believe I see on Marketwatch that RBC Capital just reiterated buy and $20 target on October 7th. Anyone catch that? Analysts don’t mean sh!t to me…but RBC is usually mildly insightful.

$NUVB love this one and not finding a reason it's down. Added more to my core. Anyone have anything tangible for the SP decline?